Why the study?
Is dyslipidemia associated with an increased risk of eGFR decline and incident chronic kidney disease in the general population?
Is dyslipidemia associated with an increased risk of eGFR decline and incident chronic kidney disease in the general population?
Dyslipidemia is an independent risk factor for eGFR decline and the development of incident chronic kidney disease.
Answers are grounded in this paper and cite their sources.
Dyslipidemia may flag higher CKD risk for monitoring; leaves open whether lipid modification alters eGFR decline in general populations.
Increased triglycerides and high levels of total cholesterol and low-density lipoprotein were independently associated with an increased likelihood of estimated glomerular filtration rate (eGFR) decline and development of incident chronic kidney disease in the general Zhejiang population.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: